Evidence map›Paper›PMID 41299373›Full record

ArticleBMC cancer2025

Reducing breast biopsy at MRI: comparison of minimum ADC cutoff and mean ADC cutoff identified by the ECOG-ACRIN A6702 multicenter trial.

Fang Wu, Fangyi Xu, Jie He, Hongjie Hu, Xia Song, Shufeng Fan, Dongying Su

Abstract readMulticenter StudyComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fang WuDepartment of Radiology, The Second Affiliated Hospital of Zhejiang Chinese Medical University , 318 Chaowang Road, Gongshu District, Hangzhou, Zhejiang Province, 310005, China.
Fangyi XuDepartment of Radiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 3 Qingchun East Road, Shangcheng District, Hangzhou, Zhejiang Province, 310010, China.
Jie HeDepartment of Radiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 3 Qingchun East Road, Shangcheng District, Hangzhou, Zhejiang Province, 310010, China.
Hongjie HuDepartment of Radiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 3 Qingchun East Road, Shangcheng District, Hangzhou, Zhejiang Province, 310010, China.
Xia SongDepartment of Radiology, The Second Affiliated Hospital of Zhejiang Chinese Medical University , 318 Chaowang Road, Gongshu District, Hangzhou, Zhejiang Province, 310005, China.
Shufeng FanDepartment of Radiology, The Second Affiliated Hospital of Zhejiang Chinese Medical University , 318 Chaowang Road, Gongshu District, Hangzhou, Zhejiang Province, 310005, China.
Dongying SuDepartment of Radiology, The Second Affiliated Hospital of Zhejiang Chinese Medical University , 318 Chaowang Road, Gongshu District, Hangzhou, Zhejiang Province, 310005, China. sdying0909@163.com.

Funding

Zhejiang Province Medical Science and Technology Project 2024KY1230
6 · The paper itself

Abstract

backgroundThe aim of this study was to validate the generalisability of the ECOG-ACRIN A6702 multicenter trial identified mean apparent diffusion coefficient (ADC) cutoff (1.53 × 10

methodsThis dual-cohort retrospective analysis included 453 patients with 494 BI-RADS 4/5 lesions (derivation cohort: 288 patients/311 lesions; validation: 165 patients/183 lesions). ADC

resultsIn the derivation cohort, the data-derived ADC

conclusionsThe data-derived ADC

Indexed as

BreastBreast NeoplasmsDiffusion Magnetic Resonance ImagingAdultAgedBiopsyFemaleHumansMiddle AgedRetrospective StudiesSensitivity and SpecificityA6702 multicenter trialApparent diffusion coefficientBiopsyBreast cancerMagnetic resonance imaging

Identifiers

PMID41299373
PMCPMC12751245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.